Clinical Trial Update: NR in Chemo-induced Peripheral Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 trial update for NR in chemo-induced peripheral neuropathy shows termination with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer Metastatic
• Chemotherapy-induced Peripheral Neuropathy
• Endometrial Cancer
• Head and Neck Cancer
• Platinum-resistant Recurrent Ovarian Cancer

Snippet

Sponsor: Donna Hammond, PhD | Conditions: Chemotherapy-induced Peripheral Neuropathy, Breast Cancer Metastatic | Phase 2 | Status: TERMINATED | Results posted: 2023-04-12